Paroxysmal Nocturnal Hemoglobinuria: First Monthly Subcutaneous Treatment Available in Italy
Italy has approved a first-of-its-kind treatment for paroxysmal nocturnal hemoglobinuria (PNH), a rare and chronic blood disorder. The fresh therapy, Crovalimab, developed by Roche, offers a monthly subcutaneous injection that can be self-administered at home, potentially improving the quality of life for those affected by this challenging condition. The approval, granted by AIFA (Agenzia Italiana … Read more